Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ke Hong and Lianguo Ruan.
Ke Hong
Connection Strength
0.514
Lianguo Ruan
  1. Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness. Emerg Microbes Infect. 2020 Dec; 9(1):2315-2321.
    View in: PubMed
    Score: 0.229
  2. Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:671443.
    View in: PubMed
    Score: 0.058
  3. High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China. Front Immunol. 2021; 12:627844.
    View in: PubMed
    Score: 0.058
  4. Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China. J Ethnopharmacol. 2021 Sep 15; 277:113888.
    View in: PubMed
    Score: 0.058
  5. Patients with Prolonged Positivity of SARS-CoV-2 RNA Benefit from Convalescent Plasma Therapy: A Retrospective Study. Virol Sin. 2020 Dec; 35(6):768-775.
    View in: PubMed
    Score: 0.056
  6. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Mar; 7(3):ofaa102.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.